China Lorlatinib Manufacturers Factory Suppliers
By strictly implementing our production process, we will continue to improve the quality of our api integrations with virtual reality, api engineers, api quality and meet the needs of our customers as always. Our company serves a vast number of users with high-quality Lorlatinib, perfect after-sales service, excellence, pioneering and enterprising spirit. We can also provide comprehensive services such as technical solutions, customized design, engineering implementation, and after-sales service according to the needs of customers. Our company has certain brand influence in the industry, and we are equipped with mature product developers and production workers. At the same time, in terms of quality, we have strict production process standards and product inspection reports. The considerate pre-sale and after-sales service, efficient and fast logistics can guarantee the customer's purchasing experience in all aspects. Our company operates with a strict code of ethics and complies with all relevant laws and regulations. We take pride in our reputation for quality, reliability, and customer satisfaction. The company has always adhered to the concept of "integrity, pragmatism, innovation, and progress", worked hard and forge ahead to create real and lasting value for customers and create development opportunities for employees. We are guided by a set of core values that prioritize integrity, honesty, and transparency.Lorlatinib received accelerated approval in November 2018 for the second- or third-line treatment of ALK-positive metastatic NSCLC. This current approval is based on data from Study B7461006 ......
Lorbrena is an anaplastic lymphoma kinase inhibitor for metastatic non-small cell lung cancer (NSCLC). Learn about its dosing, interactions, adverse effects, warnings, and more....
Lorlatinib belongs to a group of targeted therapy drugs called tyrosine kinase inhibitors. It is also known as a cancer growth inhibitor. Lorlatinib is used to treat non-small cell lung cancer that:...
Feb 10, 2020 · Lorlatinib has antitumor activity against multiple mutant forms of the ALK enzyme, including some mutations detected in tumors at the time of disease progression on crizotinib and...
Lorlatinib improved progression-free survival (PFS) and intracranial activity versus crizotinib in patients with previously untreated, advanced, ALK -positive non–small cell lung cancer...
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that...
